Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Unwinding the genomic threads of monoclonal gammopathy of renal significance through ultra-low pass whole genome sequencing

Blood (2025) 146 (Supplement 1): 3970.

https://doi.org/10.1182/blood-2025-3970

Published: 2025

Journal Articles

Fat pad biopsy versus target organ biopsy in systemic AL amyloidosis detection

Kristina Nasr, Yan Zou, Shahzad Raza, Mazen Hanna, Jack Khouri, Jason Valent, Christy Samaras, Sandra Mazzoni, Cynthia Scott, Kimberly Hamilton, Saveta Mathur, Beth Faiman, Louis Williams, Faiz Anwer, Diana Basali

Blood (2025) 146 (Supplement 1): 3969.

https://doi.org/10.1182/blood-2025-3969

Published: 2025

Journal Articles

Underexplored mutations in plasma cell myeloma

Kirti Arora, Diana Basali, Yasar Shad, Akriti Jain, Christy Samaras, Haleema Sadia Adil, Jason Valent, Louis Williams, Jack Khouri, Sandra Mazzoni, Faiz Anwer, Abhay Singh, Shahzad Raza

Blood (2025) 146 (Supplement 1): 4025.

https://doi.org/10.1182/blood-2025-4025

Published: 2025

Journal Articles

Modeling discordant cardiac and renal recovery trajectories in AL amyloidosis using interpretable machine learning

John Hanna, Ran Zhao, Diana Basali, Shahzad Raza, Jack Khouri, Sandra Mazzoni, Christy Samaras, Beth Faiman, Ali Mehdi, Mazen Hanna, Faiz Anwer, Jason Valent, Louis Williams

Blood (2025) 146 (Supplement 1): 5743.

https://doi.org/10.1182/blood-2025-5743

Published: 2025

Journal Articles

Patients with multiple myeloma and CKD: Should we really hold off on bispecific therapy in this subgroup?

Kirti Arora, Rishi Chowdhary, Diana Basali, Christy Samaras, Akriti Jain, Deevyashali Parekh, Jason Valent, Jack Khouri, Louis Williams, Sandra Mazzoni, Abhay Singh, Faiz Anwer, Shahzad Raza

Blood (2025) 146 (Supplement 1): 2248.

https://doi.org/10.1182/blood-2025-2248

Published: 2025

Journal Articles

Real-world outcomes with teclistamab in relapsed/refractory multiple myeloma and severe renal failure: A propensity matched multi-center retrospective study using trinetx database

Deevyashali Parekh, Beth Faiman, Sandra Mazzoni, Louis Williams, Jack Khouri, Hossam M. Ali, Utkarsh Goel, Jason Valent, Diana Basali, Christy Samaras, Tara Roy, Alexandra McDonald, Faiz Anwer, Majid Jaberi, Kirti Arora, Haleema Sadia Adil, Julie Bevacqua, Rahul Seth, Shahzad Raza

Blood (2025) 146 (Supplement 1): 6372.

https://doi.org/10.1182/blood-2025-6372

Published: 2025

Journal Articles

Real-world outcomes with CAR-T therapy in relapsed/refractory multiple myeloma and severe renal failure: A propensity matched multi-center retrospective Study using trinetx database

Deevyashali Parekh, Sandra Mazzoni, Jason Valent, Louis Williams, Jack Khouri, Diana Basali, Kirti Arora, Saveta Mathur, Haleema Sadia Adil, Anousheh Paracha, Majid Jaberi, Faiz Anwer, Rahul Seth, Shahzad Raza

Blood (2025) 146 (Supplement 1): 4593.

https://doi.org/10.1182/blood-2025-4593

Published: 2025

Journal Articles

Talquetamab in Relapsed/Refractory multiple myeloma with renal impairment: A quaternary cancer center experience

Hossam M. Ali, Sandra Mazzoni, Utkarsh Goel, Jack Khouri, Faiz Anwer, Asfand Yar Cheema, Louis Williams, Diana Basali, Christy Samaras, Beth Faiman, Willem van Heeckeren, Kimberly Hamilton, Joslyn Rudoni, Mikhaila Rice, Jonathan Kissam, Cynthia Scott, Saveta Mathur, Jason Valent, Shahzad Raza

Blood (2025) 146 (Supplement 1): 6367.

https://doi.org/10.1182/blood-2025-6367

Published: 2025

Journal Articles

US Physicians' Perspective and Practice Patterns for the Management of Transplant-Eligible-Newly Diagnosed Multiple Myeloma

Yara Shatnawi, Zainab Motiwala, Faiz Anwer, Danai Dima, Louis S Williams, Nausheen Ahmed, Sandra Mazzoni, Jack Khouri, Joslyn Rudoni, Mikhaila Rice, Diana Basali, Christy J. Samaras, Jason Valent, Al-Ola Abdallah, Tara Roy, Beth M. Faiman, Shahzad Raza

Blood (2024) 144 (Supplement 1): 7044.

https://doi.org/10.1182/blood-2024-212202

Published: 2024

Journal Articles

A Pilot Screening and Patient Navigation Program for Early Detection of Multiple Myeloma to Address Cancer Disparities

Diana Basali, Heather McKee Hurwitz, Kim Bell, Kimberly Sanders, Mark Ribbins, Raymond Jackson, Jason Valent

Blood (2024) 144 (Supplement 1): 5167.

https://doi.org/10.1182/blood-2024-210614

Published: 2024

Journal Articles

Outcomes of Salvage VDT-PACE-like Regimens in Relapsed-Refractory Multiple Myeloma: 10-Year Experience of a Large Academic Institution

Arooj Ahmed, Danai Dima, Kerri Row, Fauzia Ullah, Hussein Awada, Diana Basali, Heena Kurish, Mikhaila Rice, Joslyn Rudoni, Marissa Duco, Beth M. Faiman, Jack Khouri, Sandra Mazzoni, Louis S. Williams, Shahzad Raza, Christy J. Samaras, Jason Valent, Faiz Anwer

Blood (2023) 142 (Supplement 1): 4724.

https://doi.org/10.1182/blood-2023-182972

Published: 2023

Journal Articles

Insights into Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: A 12-Year Experience of a Large Academic Center

Danai Dima, Fauzia Ullah, Serhan Unlu, Diana Basali, Mahir Khan, Abdullah Saeed Khan, Xuefei Jia, Majid Jaberi-Douraki, Beth M. Faiman, Sandra Mazzoni, Louis S. Williams, Christy J. Samaras, Jason Valent, Faiz Anwer, Jack Khouri, Shahzad Raza

Blood (2023) 142 (Supplement 1): 3407.

https://doi.org/10.1182/blood-2023-181365

Published: 2023

Journal Articles

Outcomes of Venetoclax-Based Therapy in Patients with Daratumumab-Refractory t(11;14) Positive Light Chain Amyloidosis

Mark Orland, Danai Dima, Fauzia Ullah, Hussein Awada, Diana Basali, Beth M. Faiman, Cynthia Scott, Sandra Mazzoni, Louis S. Williams, Christy J. Samaras, Jason Valent, Faiz Anwer, Shahzad Raza, Jack Khouri

Blood (2023) 142 (Supplement 1): 2031.

https://doi.org/10.1182/blood-2023-183030

Published: 2023

Journal Articles

Outcomes in AL Amyloidosis: A Single Institution Experience

Diana Basali, MD, Jennifer Tran, DO, Wei Wei, MS, Sherry Fada, Brittany Lewis, Jason Valent, MD

Blood (2020) 136 (Supplement 1): 32.

https://doi.org/10.1182/blood-2020-140619

Published: 2020

Journal Articles

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory t[11;14] Multiple Myeloma

Diana Basali, MD, Rajshekhar Chakraborty, MD, Lisa Rybicki, MS, Nathaniel Rosko, PharmD, Janice Reed, RN, Mary Ann Karam, RN, Kristen Schlueter, RN, Hayley Dysert, Beth M. Faiman, PhDCNP, Kimberly Hamilton, APRN/PA, Matt Kalaycio, MD, Jason Valent, MD

Blood (2019) 134 (Supplement_1): 5566.

https://doi.org/10.1182/blood-2019-129002

Published: 2019

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Unwinding the genomic threads of monoclonal gammopathy of renal significance through ultra-low pass whole genome sequencing

Fat pad biopsy versus target organ biopsy in systemic AL amyloidosis detection

Underexplored mutations in plasma cell myeloma

Modeling discordant cardiac and renal recovery trajectories in AL amyloidosis using interpretable machine learning

Patients with multiple myeloma and CKD: Should we really hold off on bispecific therapy in this subgroup?

Real-world outcomes with teclistamab in relapsed/refractory multiple myeloma and severe renal failure: A propensity matched multi-center retrospective study using trinetx database

Real-world outcomes with CAR-T therapy in relapsed/refractory multiple myeloma and severe renal failure: A propensity matched multi-center retrospective Study using trinetx database

Talquetamab in Relapsed/Refractory multiple myeloma with renal impairment: A quaternary cancer center experience

US Physicians' Perspective and Practice Patterns for the Management of Transplant-Eligible-Newly Diagnosed Multiple Myeloma

A Pilot Screening and Patient Navigation Program for Early Detection of Multiple Myeloma to Address Cancer Disparities

Outcomes of Salvage VDT-PACE-like Regimens in Relapsed-Refractory Multiple Myeloma: 10-Year Experience of a Large Academic Institution

Insights into Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: A 12-Year Experience of a Large Academic Center

Outcomes of Venetoclax-Based Therapy in Patients with Daratumumab-Refractory t(11;14) Positive Light Chain Amyloidosis

Outcomes in AL Amyloidosis: A Single Institution Experience

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory t[11;14] Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only